Skip to main content

SEPTICEMIA

Image
By

 WHAT IS SEPTICEMIA?

Septicemia, or sepsis, is the clinical name for blood poisoning by bacteria. It is the body's most extreme response to an infection. Sepsis that progresses to septic shock has a death rate as high as 50%, depending on the type of organism involved. Sepsis is a medical emergency and needs urgent medical treatment. Without treatment, sepsis can quickly lead to tissue damage, organ failure, and death.


Septicemia is an infection that occurs when bacteria enter the bloodstream and spread. It can lead to sepsis, the body’s reaction to the infection, which can cause organ damage and even death. Septicemia is more common in people who are hospitalized or have other medical conditions. It requires immediate medical attention and antibiotic treatment.Septicemia, sometimes called blood poisoning, is an infection that occurs when germs get into the bloodstream and spread. The germs are usually bacteria but also can be viruses or fungi.


WHAT CAUSES SEPSIS?

These infections are most often associated with sepsis:

  • Lung infections (pneumonia)

  • Urinary tract infections

  • Skin infections

  • Infections in the intestines or gut

These 3 germs most frequently develop into sepsis are:

  • Staphylococcus aureus (staph)

  • Escherichia coli (E. coli)

  • Some types of Streptococcus.


  • WHO IS AT RISK FOR SEPSIS?

  • n infection can happen to anyone, but there are certain risk factors that put people at higher risk for developing sepsis. These include people with:

    • Chronic medical conditions such as diabetes, cancer, lung disease, immune system disorders, and kidney disease

    • Weak immune systems

    • Community-acquired pneumonia

    • A previous hospitalization (especially hospitalization for an infection)

    Also at risk are:

    • Children younger than 1 year of age

    • Adults age 65 and older

    What are the symptoms of sepsis?

    The following are the most common symptoms of sepsis. However, each person may experience symptoms differently.

    People with sepsis often develop a hemorrhagic rash—a cluster of tiny blood spots that look like pinpricks in the skin. If untreated, these gradually get bigger and begin to look like fresh bruises. These bruises then join together to form larger areas of purple skin damage and discoloration.

    Sepsis develops very quickly. The person rapidly becomes very ill, and may:

    • Lose interest in food and surroundings

    • Become feverish

    • Have a high heart rate

    • Become nauseated

    • Vomit

    • Become sensitive to light

    • Complain of extreme pain or discomfort

    • Feel cold, with cool hands and feet

    • Become lethargic, anxious, confused, or agitated

    • Experience a coma and sometimes death.


    • CAUSES OF SEPSIS

    • Bacteria, viruses, and fungi can enter the bloodstream in many ways, for example:

      The body usually can remove a small number of germs naturally. But if germs continue to grow and spread, that can lead to septicemia.


      DIAGNOSIS AND TREATMENT 

    • The diagnose sepsis, your healthcare provider will look for a variety of physical finding such as low blood pressure, fever, increased heart rate, and increased breathing rate. Your provider will also do a variety of lab tests that check for signs of infection and organ damage. Since some sepsis symptoms (such as fever and trouble breathing) can often be seen in other conditions, sepsis can be hard to diagnose in its initial stages.
    • Sepsis is a life-threatening emergency that needs immediate medical attention. People with sepsis are hospitalized and treatment is started as quickly as possible. Treatment includes antibiotics, managing blood flow to organs, and treating the source of the infection. Many people need oxygen and IV (intravenous) fluids to help get blood flow and oxygen to the organs. Depending on the person, help with breathing with a ventilator or kidney dialysis may be needed. Surgery is sometimes used to remove tissue damaged by the infection.




Comments

Post a Comment

Popular posts from this blog

THE SEROTONIN THEORY OF DEPRESSION

By
  DEPRESSION Depression, that is major depressive disorder (MDD), is a calamity for individuals and society. If we have not experienced it ourselves, we all know someone who has been struck by this disease. Twenty percent of women and 15 per cent of men suffer at least one episode in their lifetime. In the USA, the lifetime prevalence in the general population is estimated at 16.2 per cent. MDD is characterized by two or more weeks of depressed mood or diminished interest, associated with symptoms such as disturbed sleep, decrease in appetite and libido, psychomotor changes, reduced concentration, excessive guilt and suicidal thoughts or attempts. It is insidious and often recurrent. Although depressive episodes can be treated well with antidepressant medication, structured forms of psychotherapy or a combination of these, the rate of recurrence is high, with each episode raising the probability of a new one by 16 per cent. MDD is the second leading cause of disability worldwide, i...
Post a Comment
Read more

GLOBAL COLLABORATION PROVIDES INSIGHT ON RARE NEUROENDOCRINE TUMORS

By
  Researchers in Madrid recently wrapped up the largest-yet genomic study of rare neuroendocrine tumors, known as pheochromocytomas and paragangliomas (PPGLs), which identified a seemingly perfect panel of metastatic disease markers as well as a group of patients who could potentially benefit from immunotherapy. The objective here is a better means to predict, at the time of diagnosis of the primary tumor, whether patients will be immediately affected by cancer spread, according to Bruna Calsina, a researcher at the Spanish National Cancer Research Center (CNIO).  Surgical removal of the primary tumor is standard practice, with physicians relying on clinical characteristics of the tumor and patient symptoms in the absence of reliable molecular markers of metastatic potential, she says. The central problem is that PPGLs are exceedingly rare. Samples from more than 100 patients with metastatic disease were analyzed in the latest study, published in  Nature Communications , ...
Post a Comment
Read more